DermTopic: Atopic Dermatitis

Filter Your Results

 

News

 

eRelevance Uncovers Marketing Truths, EADV Data, Primetime f…

The State of Aesthetic Healthcare Marketing 2017 from eRelevance shows that nearly 60 percent of aesthetic physicians sa…

DermWire.com

EADV News: Positive Study Results for Dupixent® (dupilumab)…

Dupixent with topical corticosteroids (TCS) significantly improved measures of overall disease severity, skin clearing, …

U.K Survey Reveals Eczema Treatment Knowledge Gap

Two thirds of UK eczema patients don’t understand that bacteria play a crucial role in their condition despite stu…

Lilly’s Baricitinib Performs Well in Phase 2 AD Study

Lilly’s experimental JAK inhibitor Baricitinib in combination with a mid-potency topical corticosteroid (TCS) sign…

Vanda's Tradipitant Improves Itch and Disease Severity in AD…

Vanda Pharmaceuticals Inc.’s tradipitant improved the intensity of the worst itch patients experienced, as well as…

Lilly to Present New Data for Olumiant® and Taltz® at EADV

Eli Lilly and Company will present Phase 2 safety and efficacy data evaluating Olumiant® (baricitinib) for the …

AD Breakthrough? Medimetriks’ MM36 Achieves Rapid Itch Rel…

Medimetriks’ PDE4 inhibitor, MM36, appears to be safe, well-tolerated and provides rapid itch relief when applied …

GBI Research: Global Dermatology Pipeline Will See Shift Tow…

The global dermatology pipeline, which currently comprises 850 products with a disclosed stage of development, is primar…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.